MENLO PARK, Calif.– Pacific Biosciences of California, Inc., (Nasdaq:PACB) and HistoGenetics, a global leader in Human Leukocyte Antigen (HLA) sequence-based typing (SBT), announced today that HistoGenetics has selected the PacBio DNA Sequencing platform for its unique ability to sequence full-length HLA genes and to provide fully phased HLA alleles. HistoGenetics has purchased two PacBio RS […]
Hologic, Inc. (Hologic or the Company), a leading developer, manufacturer and supplier of premium diagnostic products, medical imaging systems and surgical products, with an emphasis on serving the healthcare needs of women, today announced that its subsidiary, Tepnel Pharma Services (Tepnel), has successfully achieved authorised customer service provider (CSP) status in the Ion Torrent Service […]
SAN DIEGO — Illumina (NASDAQ:ILMN) announced today that the company has filed a new patent infringement suit against Ariosa Diagnostics, Inc. Illumina is seeking all available remedies, including injunctive relief. The new suit, filed in the U.S. District Court for the Northern District of California, is based on Ariosa’s infringement of U.S. Patent No. 7,955,794, […]
SAN JOSE, Calif.– BD Biosciences, a segment of BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced the launch of the BD FACSPresto™ Near Patient CD4 Counter system that provides absolute and percentage results of CD4 T lymphocytes and hemoglobin (Hb) concentration in whole blood samples to stage and […]
AUSTIN, Texas — Luminex Corporation (NASDAQ: LMNX) today announced that norovirus will be the fourth assay in the launch menu for its new sample-to-answer system, ARIES™. The assay is designed to test for both GI and GII genogroups in a single, easy-to-use cassette. The previously announced items in the five assay launch menu targeted for […]
Bangalore: With the aim of making genomics-based diagnostics accessible and affordable for people in India, Strand Life Sciences Private Limited, a global life sciences & clinical genomics company headquartered in Bangalore, entered into a partnership with theMazumdar-Shaw Medical Foundation (MSMF) to set up the Strand at Mazumdar-Shaw (SAMS) translationallabin the Mazumdar-Shaw Centre for Translational Research […]
SanFrancisco,Calif.–-CollabRx, Inc. (NASDAQ: CLRX), a leading provider of software and IT systems that support clinical decision-making in oncology, and Affymetrix, Inc. (NASDAQ: AFFX), an industry leader in genomics analysis, today announced an agreement to optimize the use of CollabRx’s Genetic Variant Annotation (GVA) Service™ in connection with Affymetrix’ OncoScan™ FFPE Assay Kit and CytoScan® Cytogenetics […]
GERMANTOWN, Maryland — QIAGEN today announced plans to combine its three Maryland sites into two campuses and invest an additional $10 million to accommodate expected future growth. The company will close its current site at Gaithersburg, Maryland and move the Gaithersburg activities to nearby Germantown, Maryland, by early 2015. The Germantown campus will also become […]
MINNEAPOLIS — Techne Corporation (NASDAQ: TECH) (d/b/a Bio-Techne) announced today that its R&D Systems China Co. Ltd. (R&D China) subsidiary has entered into an agreement to acquire 100% of the ownership interest of Shanghai PrimeGene Bio-Tech Co. (PrimeGene). PrimeGene is a leader in the China market in the development, manufacture and distribution of recombinant proteins […]
Toronto, Ontario — SQI Diagnostics Inc. (“SQI” or the “Company”) (TSX-V: SQD), a life sciences and diagnostics company that develops and commercializes proprietary technologies and products for advanced microarray diagnostics, today announced that it has closed its previously announced public offering (the “Offering”). Pursuant to the Offering, SQI issued 8,400,000 units of the Company (“Units”) […]
Pay Invoice
Latest Blogs
-
New Report Details Higher Education Science R&D Spending
February 27, 2026 3:23 pm
-
Single Use Leads Bioreactor Market Growth
December 30, 2025 6:04 pm
Sitemap
Your Data and Privacy
About Us
IBO (Instrument Business Outlook) is a twice-monthly newsletter aimed at providing decision-makers with the latest and most complete information available on the life science and analytical instrument industry, and lab product markets. IBO delivers the latest curated industry news, information and trends, as well as SDi data and analysis to deliver the maximum in industry insight with a minimum time investment for executives and investors.
